Navigation Links
Transcept Pharmaceuticals to Present at the BioCentury Thomson Reuters Newsmakers in the Biotech Industry Conference on September 16, 2009
Date:9/2/2009

RICHMOND, Calif., Sept. 2 /PRNewswire-FirstCall/ -- Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT) today announced that it will present at the BioCentury Thomson Reuters Newsmakers in the Biotechnology Industry Conference on Wednesday, September 16, 2009 at 11:00 am EDT.

A live audio webcast and replay of the presentation will be available on the investor webpage at www.transcept.com.

About Transcept

Transcept Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in neuroscience. The most advanced Transcept product candidate is Intermezzo(R) (zolpidem tartrate sublingual tablet), which is currently being reviewed by the U.S. Food and Drug Administration (FDA) as a prescription sleep aid for use in the middle of the night at the time a patient awakens and has difficulty returning to sleep. October 30, 2009 is the PDUFA target date for the FDA to take action on its review of the Intermezzo(R) NDA. Transcept and Purdue Pharmaceutical Products, L.P. have entered into a collaboration agreement for the development and commercialization of Intermezzo(R) in the United States. For further information, please visit the company's website at: www.transcept.com.

About Intermezzo(R)

Intermezzo(R) (zolpidem tartrate sublingual tablet), the lead product candidate at Transcept, has the potential to be the first prescription sleep aid specifically approved for use in the middle of the night at the time a
'/>"/>

SOURCE Transcept Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Purdue Pharmaceutical Products L.P. and Transcept Pharmaceuticals, Inc. Sign Exclusive Agreement to Commercialize Intermezzo(R) in the United States
2. Transcept Pharmaceuticals to Present at the Bank of America and Merrill Lynch 2009 Health Care Conference
3. Transcept Pharmaceuticals to Present at 11th Annual BIO CEO & Investor Conference
4. Transcept Pharmaceuticals Announces FDA Acceptance for Review of New Drug Application for Intermezzo(R)
5. Transcept Pharmaceuticals, Inc. to Present at the Natixis Bleichroeder Second Annual Hidden Gems Conference
6. Transcept Pharmaceuticals Appoints Key Senior Executives
7. Transcept Pharmaceuticals to Participate in Middle-of-the-Night (MOTN) Insomnia Investor Panel
8. Poniard Pharmaceuticals To Present at Three Upcoming Investor Conferences in September
9. Optimer Pharmaceuticals Announces Presentations of Additional Phase 3 Fidaxomicin and Prulifloxacin Data at Upcoming ICAAC Annual Meeting
10. Jiangbo Pharmaceuticals to Present at Rodman & Renshaw Annual Global Investment Conference
11. Access Pharmaceuticals to Present at the Rodman & Renshaw Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... BioConvergence team members Curtis Strother and ... BioLogistics Summit in San Francisco earlier this month. ... IQ and IQPC, addressed the increasingly complex logistical ... attributed to current trends of globalization, outsourcing, and ... is an increase in movement, which is often ...
(Date:6/19/2013)... Diego, CA (PRWEB) June 19, 2013 ... pipettes, Pipette.com is now stocked with Simport’s Dropette® ... all aimed at the customer doing basic biology, chemistry ... work, and serology). , For over 35 years, Simport ... disposable plastic labware - products like the Simport Dropette®. ...
(Date:6/18/2013)... (PRWEB) June 18, 2013 ExakTime, ... in North America, has introduced AccountLinx Plus, a ... payroll records between ExakTime’s software and industry-leading payroll ... software setup and keeps employee databases up-to-date in ... a business’ current payroll software, directly into ExakTime’s ...
(Date:6/18/2013)... 2013 Nasseo, Inc. today announces that ... out of hundreds of applicants by the Arizona ... Innovation Challenge . The Arizona Innovation Challenge (AIC) awards ... commercialization challenge, granting a financial award to what it ... Nasseo’s state of the art dental and orthopedic implant ...
Breaking Biology Technology:BioConvergence® Presents at BioLogistics Summit on Risk Matrix for Biosamples during Shipment 2Leading Pipette Distributor Pipette.com Now Stocks Transfer Pipettes: Simport’s Dropette and Heathrow Scientific Disposable Plastic Transfer Pipettes 2ExakTime Introduces AccountLinx Plus 2Nasseo Named 2013 Innovation Challenge Winner by Arizona Commerce Authority 2
... JERSEY CITY, New Jersey, October 29, Rosetta Genomics ... of microRNA-based diagnostics, announced today its,management will present ... 3-4, 2008 at the Waldorf-Astoria Hotel in New ... recently discovered, naturally occurring, small,RNAs that act as ...
... Inverness Medical,Innovations, Inc. (Amex: IMA ), a ... financial results for the quarter,ended September 30, 2008., ... net revenue of,$438.8 million compared to net revenue of ... increase was primarily due to $118.7 million,of incremental revenue ...
... Oct. 29 The Healthcare Scoop,( http://www.healthcarescoop.com ... patient stories about healthcare, will now extend ... organizations, according,to MaryAnn Stump, president, Consumer Aware. ... including Courage Center, Mayo,Clinic, The Emily Program, ...
Cached Biology Technology:Rosetta Genomics to Present at Oppenheimer's 19th Annual Healthcare Conference 2Rosetta Genomics to Present at Oppenheimer's 19th Annual Healthcare Conference 3Inverness Medical Innovations Announces Third Quarter 2008 Results 2Inverness Medical Innovations Announces Third Quarter 2008 Results 3Inverness Medical Innovations Announces Third Quarter 2008 Results 4Inverness Medical Innovations Announces Third Quarter 2008 Results 5Inverness Medical Innovations Announces Third Quarter 2008 Results 6Inverness Medical Innovations Announces Third Quarter 2008 Results 7Inverness Medical Innovations Announces Third Quarter 2008 Results 8Inverness Medical Innovations Announces Third Quarter 2008 Results 9Inverness Medical Innovations Announces Third Quarter 2008 Results 10Inverness Medical Innovations Announces Third Quarter 2008 Results 11Inverness Medical Innovations Announces Third Quarter 2008 Results 12Inverness Medical Innovations Announces Third Quarter 2008 Results 13Inverness Medical Innovations Announces Third Quarter 2008 Results 14Inverness Medical Innovations Announces Third Quarter 2008 Results 15Inverness Medical Innovations Announces Third Quarter 2008 Results 16Healthcare Scoop Expands Consumer Conversation to Dialogue with Premier Healthcare Organizations 2Healthcare Scoop Expands Consumer Conversation to Dialogue with Premier Healthcare Organizations 3
(Date:6/19/2013)... canary seeds bred specifically for human consumption qualifies as ... with celiac disease (CD), scientists have confirmed in a ... Food Chemistry . , Joyce Irene Boye and ... in the United States alone have CD. They develop ... and other grains that contain gluten-related proteins. Boye,s team ...
(Date:6/19/2013)... In fall 2012, the European Medicines Agency (EMA) ... the first ever gene therapy for clinical use ... company, had developed AAV-LPL S447X for the treatment ... lipase deficiency (LPLD) which affects approximately one or ... causes severe, life-threatening inflammations of the pancreas. Afflicted ...
(Date:6/18/2013)... awarded a $394,300 grant from the Tarrant Regional ... in the new facilities of the 150-mile Integrated ... professor of civil engineering, will investigate the best ... water in an effort to eliminate biological growths ... monochloramine is widely practiced throughout the United States. ...
Breaking Biology News(10 mins):No danger of cancer through gene therapy virus 2UT Arlington research to benefit quality, flow in 150-mile Integrated Pipeline 2
... of cardiac therapeutics have long looked to the future when ... one,s own heart cells. A study published in the February ... American Heart Association, shows that heart stem cells from children ... heart in an animal model. ...
... of Exeter has revealed that couples with similar personalities make ... least in the world of zebra finches. Researchers found ... a willingness to explore, did a much better job of ... were markedly different in personality, chicks didn,t fare as well ...
... For the first time, scientists have mapped the genome--the genetic ... efforts to maintain the genetic diversity of captive and wild ... be used to help improve our understanding of the evolution ... National Science Foundation, the orangutan study appears in the Jan. ...
Cached Biology News:Using a child's own stem cells to repair their heart looks promising 2Opposites may attract, but they don't make better parents 2Scientists determine what makes an orangutan an orangutan 2Scientists determine what makes an orangutan an orangutan 3
... Ideal for staining westerns and includes stickers ... Pour spouts in each corner facilitate pouring ... be used for identification. Lid is designed ... for staining several gels simultaneously. Lid also ...
... 20 years of experience in providing versatile ... the Freedom EVO platform delivers even more ... future needs. Together with the new easy-to-use ... to successfully operate genomics, proteomics, and drug ...
... in any standard fixed-angle microcentrifuge rotor ... g.,Spin- centrifuge tube filters consist of ... centrifuge tube. They filter by centrifugation ... sample preparation, removal of cells from ...
... number is a new product ... Cornings product number. If showing ... under the old Sigma-Aldrich number ... for assistance. Material: polystyrene flat ...
Biology Products: